Goodwin is proud to be a platinum sponsor of the 2024 Global Fund Finance Symposium. As next week’s conference approaches and our clients, colleagues, and friends head toward Miami, the Goodwin Fund Finance team has paused to...more
2/23/2024
/ Asia ,
Asia Pacific ,
Banking Crisis ,
Banks ,
Capital Markets ,
Credit Facilities ,
Equity Financing ,
EU ,
Financial Markets ,
Financing ,
Fund Sponsors ,
Investment Funds ,
Private Investment Funds ,
Refinancing ,
Secured Notes ,
Sponsors ,
Structured Finance ,
Structured Financial Products
As 2022 comes to a close, we review Big Molecule Watch’s top five biosimilar regulatory developments of the year...more
1/3/2023
/ America Invents Act ,
Biden Administration ,
Biosimilars ,
China ,
Drug Pricing ,
EU ,
Executive Orders ,
Food and Drug Administration (FDA) ,
Governor Newsom ,
Interchangeability ,
Life Sciences ,
Orange Book ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Purple Book ,
USPTO
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recently adopted positive opinions for three biosimilar products. On June 23, 2022, CHMP recommended the grant of a marketing...more